to score with our research focus 'Infection and Immunity' and received many research funds for SARS CoV2 and COVID19 research.101.4 million euros is considerable for a divisional university like the MHH
preparedness was communicated in public? Further information Collaborative Research Centre (SFB) 900 SIG-COV / Characterization of SARS-CoV-2 immunity for cellular immunotherapy Project leader: Prof. Dr. Britta
complications in pregnancy ► Influence of the pandemic and acceptance of vaccination against SARS-Cov2 in women who wish to have children ► Desire to have children and family planning in organ transplants
"Responses of human bronchial epithelial cells and microvascular lung endothelial to serum from SARS CoV-2 infected patients with different WHO Clinical Progression Scales (WHO-CPS)" Completed doctoral theses [...] protein alpha1-antitrypsin (AAT) to prevent serious COVID-19 course with an unfavorable outcome of SARS-COV2 corona virus infected patients. The project includes examinations of immune cells from healthy donors
Jun;77:103404. doi:10.1016/j.scr.2024.103404. Epub 2024 Mar 24. PMID: 38552356. CIBERESUCICOVID Project (COV20/00110, ISCIII). MicroRNA-centered theranostics for pulmoprotection in critical COVID-19. Perez-Pons
Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol 2020;34(6):e241-e242 DOI: 10.1111/jdv [...] Czerwienska B, Wiecek A, Peters B, Nilsson A, Schwab M, Rothfuss K, Lubbert C, Staessen JA, Beige J, CRIT-COV-U investigators. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients. EC [...] results of an inter-laboratory comparison. Thromb Haemost 2021 DOI: 10.1055/a-1535-9002 Mallet V, Keta-Cov research group. Intravenous ketamine is a risk factor for jaundice in Covid-19 patients. J Hepatol
pathogens include human metapneumovirus, rhinovirus, influenza virus and the novel coronavirus SARS Cov2. To date, there is no specific treatment for respiratory infections caused by RSV and co-circulating
Braunschweig Maureen Obara Research Topic: Spatial antibody treatment strategies of pulmonary SARS-COV-2 infection Supervisor: Prof. Dr. Ulrich Kalinke, Institute for Experimental Infection Research, Twincore